Samara Capital
Consumer
RAW Pressery knocks at FMCG giant, mid-market PE fund for survival capital
Cold-pressed juices maker RAW Pressery is in talks with a few strategic and financial investors to raise capital in a ......
Healthcare
PAG joins Indian PE firms for pharma platform, eyes second deal
Hong Kong-based alternative investment firm PAG Asia Capital has joined two Indian private equity firms to build a bulk-drugs platform ......
Healthcare
PE firms near club deal for majority stake in Anjan Drug
Two homegrown private equity firms have teamed up with an Asian alternative investment firm to strike a deal for Chennai-based ......
General
Grapevine: Promoter, two PE firms to part-exit Sahajanand; SoftBank may back Unacademy
The promoter of Sahajanand Medical Technologies Pvt. Ltd, India’s largest cardiac stent maker, along with two private equity firms, plan ......
People
Samara Capital, Goldman Sachs and Janchor acqui-hire a unit of HR Cornucopia
FirstMeridian, an HR investment platform of private equity firm Samara Capital, Goldman Sachs and Janchor Partners, has acqui-hired a business ......
General
Grapevine: Reliance, Samara eye stake in Future Retail; Good Host buys varsity facilities
Several suitors including Reliance Retail Ltd and private equity firm Samara Capital are looking to buy a stake in Kishore ......
Consumer
Samara Capital ropes in FMCG veteran as MD of More Retail
Private equity firm Samara Capital has appointed a former top executive at Colgate-Palmolive, Vinod Nambiar, as managing director of its ......
Consumer
Coronavirus: Which PE portfolio firms are in the line of direct fire?
Private equity firms can expect some of their portfolio companies in travel, food, hospitality and entertainment to take a hit ......
Healthcare
Quadria Capital ups stake in healthcare firm, buys out Samara
Quadria Capital, which is raising its second healthcare-focussed private equity vehicle, has doubled down on a portfolio company that’s part ......
Healthcare
CX Partners, Samara in talks with drugmakers for club deal with two LPs
Homegrown private equity firms CX Partners and Samara Capital are scouting for investment opportunities in companies that make bulk drugs ......